Prediction of nocturnal hypoglycaemia with bedtime glucose level during continuous subcutaneous insulin infusion in type 2 diabetics

National Medical Journal of China

Volumn 90, Issue 42, 2010, Pages 2962-2966

  Li, Ming ^a   Zhou, Jian ^a   Bao, Yu Qian ^a   Lu, Wei ^a   Jia, Wei Ping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Boold glucose self monitoring; Continuous subcutaneous insulin infusion; Diabetes mellitus, type 2; Hypoglycemia

Indexed keywords

GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NOCTURNAL HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; YOUDEN INDEX; CHEMICALLY INDUCED DISORDER; CIRCADIAN RHYTHM; HYPOGLYCEMIA; INSULIN INFUSION; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIA; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED;

EID: 84871424951     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.42.005     Document Type: Article

References (18)

1. 2006, 86: 2524-2526.
2. Mastrototaro J. The MiniMed continuous glucose monitoring system (CGMS). J Pediatr Endocriol Metab, 1999, 12:751-758.
3. 2006, 86:2154-2157.
4. Boland E, Monsod T, Delucia M, et al. Limitations of convetional methods self-monitoring of blood glucose. Diabetes Care, 2001, 24: 1858-1862.
5. Klonoff D C. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care, 2005, 28:1231-1239.
6. Lopez M J, Oyarzabal M, Barrio R, et al. Nocturnal hypoglycaemia in IDDM patients younger than 18 years. Diabet Med, 1997, 14: 772-777.
7. Bode B W, Gross T M, Thornton K R, et al. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin. Diabetes Res Clin Pract, 1999, 46:183-190.
8. Boland E, Monsod T, Delucia M, et al. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care, 2001, 24: 1858-1862.
9. Wentholt I M, Maran A, Masurel N, et al. Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations. Diabet Med, 2007, 24: 527-532.
10. DirecNet Study Group. Eight-Point Glucose Testing Versus the Continuous Glucose Monitoring System in Evaluation of Glycemic Control in Type 1 Diabetes. J Clin Endocrinol Metab, 2005, 90: 3387-3391.
11. Mozdzan M, Ruxer J, Loba J, et al. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system. Adv Med Sci, 2006, 51:133-136.
12. Amin R, Ross K, Acerini CL, et al. Hypoglycemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: use of con tinuous glucose monitoring system. Diabetes Care, 2003, 26:662-667.
13. 2005, 13:102-104.
14. Pramming S, Thorsteinsson B, Bendtson I, et al. Nocturnal hypoglycaemia in patients receiving conventional treatment with insulin. Br Med J (Clin Res Ed), 1985, 291:376-379.
15. Shalwitz R A, Farkas-Hirsch R, White N H, et al. Prevalence and consequences of nocturnal hypoglycemia among conventionally treatd children with diabetes mellitus. J Pediatr, 1990, 116: 685-689.
16. 2006, 22: 323-324.
17. 2000:148-149.
18. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care, 2010, 33: Suppl 1: S11-61.